Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02022826 · ClinicalTrials.gov registry record · NA
Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis
A NA study, sponsored by Medtronic - MITG.
- Terminated
- Registry status
- NA
- Development phase
- 167
- Enrollment target
NCT02022826 is a NA study that was terminated before completion, run by Medtronic - MITG. The registered enrollment target is 167 participants.
The verdict
NCT02022826, a NA study, was terminated before completion, sponsored by Medtronic - MITG.
- TERMINATED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
Study Summary
This protocol is designed to validate use of the SPM for diagnosis of delayed gastric emptying in patients with symptoms of gastroparesis and assess impact of a SmartPill study on patient management in the gastroparetic populations. Patients with symptoms of gastroparesis will be recruited. Patients will undergo concurrent gastric scintigraphy and SPM testing to determine the presence or absence of delayed gastric emptying based on predetermined diagnostic cutoffs for each technique.
Interventions
- DEVICE SmartPill Monitoring System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2014-01 |
| Est. Completion | 2017-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02022826
The ClinicalTrials.gov registry entry for NCT02022826 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SmartPill Monitoring System is the first listed.
NCT02022826 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02022826 about?
NCT02022826 is a clinical study titled "Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis". This protocol is designed to validate use of the SPM for diagnosis of delayed gastric emptying in patients with symptoms of gastroparesis and assess impact of a SmartPill study on patient management in the gastroparetic populations. Patients with symptoms of gastroparesis will be recruited. Patient...
What is the current status of trial NCT02022826?
This trial is currently terminated. It is a NA study. The enrollment target is 167 participants. The study started on 2014-01. Estimated completion is 2017-03.
What interventions are being tested in trial NCT02022826?
The interventions under investigation include: SmartPill Monitoring System (DEVICE).
Who is sponsoring clinical trial NCT02022826?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.